Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Maxindo Karya Anugerah Tbk. (MAXI)

UBC Medical Indonesia Tbk.Trading
Maxindo Karya Anugerah Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan UBC Medical Indonesia Tbk. dan Maxindo Karya Anugerah Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp164 (kapitalisasi pasar 635,95 M, volume 24 jam 737,7 rb), sedangkan Maxindo Karya Anugerah Tbk. diperdagangkan di Rp50 (kapitalisasi pasar 480,5 M, volume 24 jam 124,4 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar, dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (737,7 rb vs 124,4 rb). Mana yang lebih baik tergantung tujuan investasimu.

LABSMAXI
Kapitalisasi Pasar
635,95 M480,5 M
Volume
737,7 rb124,4 rb
Lot
7,38 rb1,24 rb
Perputaran
120,3 jt6,22 jt
Harga Rata-rata
163,0850
Nilai Transaksi
120,3 jt6,22 jt
Harga Ekuilibrium Indikatif
16350
Volume Ekuilibrium Indikatif
1612,7 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LABS
Lihat detail
MAXI
Lihat detail

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS

Tentang Maxindo Karya Anugerah Tbk.

PT Maxindo Karya Anugerah Tbk (the Company) was established based on Notarial Deed No. 26 of Dwi Swandiani, S.H., dated July 11, 2002. The Company started its commercial operations in 2002.

Selengkapnya di halaman MAXI